Kotak Healthcare Fund vs Tata India Pharma & Healthcare Fund compare
Kotak Healthcare Fund - Regular (G)
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Fund | Kotak Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹406 Cr | ₹1208 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹100 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 11 Dec 2023 | 28 Dec 2015 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | Nifty Pharma TRI |
| Turn Over | % | 26.49% |
| Expense Ratio | 2.39 | 2.14 |
| Manager | Abhishek Bisen | Meeta Shetty |
| ISIN Code | INF174KA1PW4 | INF277K016A9 |
| Exits Load | Kotak Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Month | 4.1% | 4.66% |
| 6 Month | 18.54% | 16.53% |
| 1 Year | - | 41.34% |
| 3 Year | - | 22.4% |
| 5 Year | - | 27.33% |
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | - | 31.82% |
| 3 Year | - | 32.32% |
| 5 Year | - | 25.8% |
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Year | - | 6.67% |
| 3 Year | - | 17.46% |
| 5 Year | - | 14.22% |
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Standard Deviation | - | 14.23% |
| Sharp | - | 0.74% |
| Beta | - | 0.9% |
| Alpha | - | 2.85% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Name | Abhishek Bisen | Meeta Shetty |
| Total AUM | ₹0 Cr | ₹17847 Cr |
| Fund Manage | 33 | 5 |
| Kotak Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Scheme Name |
Kotak Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 3.31 | 5.39 |
| Small Cap | 24.27 | 23.46 |
| Large Cap | 51.29 | 40.33 |
| Mid Cap | 22.8 | 30.82 |
| Scheme Name |
Kotak Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 3.31 | 5.39 |
| Pharmaceuticals & Biotechnology | 79.49 | 76.28 |
| Healthcare Services | 17.64 | 14.31 |
| Insurance | 1.23 | 2.14 |
| Fertilizers & Agrochemicals | - | 0.83 |
| Chemicals & Petrochemicals | - | 0.39 |
| Retailing | - | 0.66 |
Top Comparisons
ICICI Prudential Balanced Advantage Fund - Growth
3Y Returns12.48%
Nippon India Balanced Advantage Fund-Growth Plan-Bonus Option
3Y Returns12.03%
HDFC Pharma and Healthcare Fund - Regular (G)
3Y Returns0%
DSP Healthcare Fund - Regular Plan - Growth
3Y Returns22.61%
Invesco India Corporate Bond Fund - Growth
3Y Returns5.74%
UTI Corporate Bond Fund - Regular Plan - Growth Option
3Y Returns5.93%
Mahindra Manulife Focused Fund - Regular Plan - Growth
3Y Returns19.92%
Edelweiss Focused Fund - Regular Plan - Growth
3Y Returns0%